About: vaccine engineering

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: vaccine engineering Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Attributes	Values
rdf:type	Item
description	Verfahren zur gezielten Anpassung von Impfstoffen (de)
rdfs:label	Impfstoffdesign (de) conception des vaccins (fr) inźenirstvo cepiv (sl) vaccine engineering (en) ワクチン工学 (ja)
skos:prefLabel	Impfstoffdesign (de) conception des vaccins (fr) inźenirstvo cepiv (sl) vaccine engineering (en) ワクチン工学 (ja)
name	Impfstoffdesign (de) conception des vaccins (fr) inźenirstvo cepiv (sl) vaccine engineering (en) ワクチン工学 (ja)
facet of	wds:Q14861085-9ec85c90-47e0-d3ad-7ef3-dbbc0489a646
facet of	vaccine
subclass of	wds:Q14861085-e3fba3af-4f34-9919-4339-19eaf3703f42
subclass of	bioengineering
Google Knowledge Graph ID	wds:Q14861085-9C8C0CA2-D239-4FD4-9673-34684FBBC102
Google Knowledge Graph ID	http://g.co/kg/g/12tb7_l3g
Google Knowledge Graph ID	/g/12tb7_l3g
skos:altLabel	načrtovanje cepiv (sl) vaccine design (en)
is field of work of	Benjamin K. Mueller
is field of work of	wds:Q88328556-711494ff-45cf-ab5f-e85c-581121fc3752
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q14861085 https://de.wikipedia.org/wiki/Impfstoffdesign
is facet of of	vector-based vaccine
is facet of of	wds:Q104783588-a7ccfdcf-43f9-8d0f-f825-9f1d0a19bdea
is field of work of	wds:Q55344433-6506E86F-A8EF-4271-9662-4CFC40AE8F8F
is subclass of of	Vaccine Platform
is subclass of of	wds:Q108028785-2f85daf7-4dbb-5cb2-dc61-0a8b361f27f6
is main subject of	Venezuelan equine encephalitis virus vectors expressing HIV-1 proteins: vector design strategies for improved vaccine efficacy Rational design of a live attenuated dengue vaccine: 2'-o-methyltransferase mutants are highly attenuated and immunogenic in mice and macaques Lymphocyte polyclonal activation: a pitfall for vaccine design against infectious agents Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques Bridging the knowledge gaps in vaccine design Understanding dengue pathogenesis: implications for vaccine design Exploiting information inherent in binding sites of virus-specific antibodies: design of an HCV vaccine candidate cross-reactive with multiple genotypes. Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines Antibodies against conserved antigens provide opportunities for reform in influenza vaccine design Analysis of Structure and Function of Putative Surface-Exposed Proteins Encoded in theStreptococcus pneumoniaeGenome: A Bioinformatics-Based Approach to Vaccine and Drug Design A triclade DNA vaccine designed on the basis of a comprehensive serologic study elicits neutralizing antibody responses against all clades and subclades of highly pathogenic avian influenza H5N1 viruses Prospects of HIV Env modification as an approach to HIV vaccine design Erratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design". Design of fully synthetic, self-adjuvanting vaccine incorporating the tumor-associated carbohydrate Tn antigen and lipoamino acid-based Toll-like receptor 2 ligand Issues in the design and implementation of vaccine trials in less developed countries Approaches to the rational design of bacterial vaccines Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA binding, oligomerization, and vaccine design Crystal Structure and Carbohydrate Analysis of Nipah Virus Attachment Glycoprotein: a Template for Antiviral and Vaccine Design Statistical analysis of MMR vaccine adverse events on aseptic meningitis using the case cross-over design. Increased immunogenicity of an anchor-modified tumor-associated antigen is due to the enhanced stability of the peptide/MHC complex: implications for vaccine design Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodies Proof of principle for epitope-focused vaccine design Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines Differential antigenic hierarchy associated with spontaneous recovery from hepatitis C virus infection: implications for vaccine design From empiricism to rational design: a personal perspective of the evolution of vaccine development. The design and proof of concept for a CD8(+) T cell-based vaccine inducing cross-subtype protection against influenza A virus Surface plasmon resonance for vaccine design and efficacy studies: recent applications and future trends. Filamentous fusion phage cloning vectors for the study of epitopes and design of vaccines Computers aid vaccine design. Polarity of immunogens: implications for vaccine design The use of animal models to guide rational vaccine design Rational design of a flavivirus vaccine by abolishing viral RNA 2'-O methylation Anti-HIV cellular immunity: recent advances towards vaccine design. HIV-Host Interactions: Implications for Vaccine Design Immunogenetics of Toxoplasma gondii informs vaccine design Insights into peptide-based vaccine design for cancer immunotherapy Staphylococcus aureus Colonization: Modulation of Host Immune Response and Impact on Human Vaccine Design. Malaria vaccine design: immunological considerations Immune systems in developed and developing countries; implications for the design of vaccines that will work where BCG does not. Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens Rational design of a plasmid DNA vaccine capable of eliciting cell-mediated immune responses to multiple HIV antigens in mice Impact of transmission intensity and age on Plasmodium falciparum density and associated fever: implications for malaria vaccine trial design Epidemiology and evolution of rotaviruses and noroviruses from an archival WHO Global Study in Children (1976-79) with implications for vaccine design Design of meningococcal factor H binding protein mutant vaccines that do not bind human complement factor H. Rational design of human metapneumovirus live attenuated vaccine candidates by inhibiting viral mRNA cap methyltransferase Use of MHC II structural features in the design of vaccines for organ-specific autoimmune diseases A novel technology for the production of a heterologous lipoprotein immunogen in high yield has implications for the field of vaccine design Rational design of vaccines Protein antigenic structures recognized by T cells: potential applications to vaccine design Implementation of an Ebola virus disease vaccine clinical trial during the Ebola epidemic in Liberia: Design, procedures, and challenges Antigenicity and Immunogenicity in HIV-1 Antibody-Based Vaccine Design HIV vaccine development by computer assisted design: the GAIA vaccine The test-negative design for estimating influenza vaccine effectiveness DyNAVacS: an integrative tool for optimized DNA vaccine design The case test-negative design for studies of the effectiveness of influenza vaccine. Human immunity and the design of multi-component, single target vaccines Phase I/II study of a candidate vaccine designed against the B and E subtypes of HIV-1. T-cell quality in memory and protection: implications for vaccine design Design of a group-randomized Streptococcus pneumoniae vaccine trial Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine development A decade of vaccines: Integrating immunology and vaccinology for rational vaccine design. Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: implications for evasion of immune responses and design of vaccine immunogens MF59. Design and evaluation of a safe and potent adjuvant for human vaccines

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software